Patent Assignment Details
NOTE:Results display only for issued patents and published applications.
For pending or abandoned applications please consult USPTO staff.
|
| Reel/Frame: | 056804/0784 | |
| Pages: | 32 |
| | Recorded: | 07/08/2021 | | |
| Attorney Dkt #: | 753952 |
| Conveyance: | ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). |
|
|
Total properties:
1
|
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
17294011
|
Filing Dt:
|
05/14/2021
|
|
Publication #:
|
|
Pub Dt:
|
01/13/2022
| | | | |
|
Title:
|
TP5, A PEPTIDE INHIBITOR OF ABERRANT AND HYPERACTIVE CDK5/P25 AS TREATMENT FOR CANCER
|
|
|
Assignee
|
|
|
|
|
| OFFICE OF TECHNOLOGY TRANSFER, NATIONAL INSTITUTES OF HEALTH |
| 6011 EXECUTIVE BOULEVARD, SUITE 325, MSC 7660 |
| BETHESDA, MARYLAND 20892-7660 |
|
|
Correspondence name and address
|
| |
LEYDIG, VOIT & MAYER, LTD.
|
| |
TWO PRUDENTIAL PLAZA, SUITE 4900
|
| |
180 NORTH STETSON AVENUE
|
| |
CHICAGO, IL 60601-6731
|
Search Results as of:
06/06/2024 04:14 PM
If you have any comments or questions concerning the data displayed,
contact
PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified:
August 25, 2017 v.2.6
|
